Go to the profile of Iovance Biotherapeutics

Iovance Biotherapeutics

 

About Iovance Biotherapeutics

Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers. The Company's lead product candidate is an adoptive cell therapy using tumor-infiltrating lymphocyte (TIL) technology being investigated for the treatment of patients with metastatic melanoma, recurrent and/or metastatic squamous cell carcinoma of the head and neck and recurrent and metastatic or persistent cervical cancer.

Therapeutic Areas

Oncology

Technologies

Other

Company Type

Biotechnology – Therapeutics

State of Ownership

Private

Sponsorship Group

Networker

Influencer Of

Topics

Topics contributed to:

Oncology

Editions participated in:

September 2017 November 2017